Progenics Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PGNX
CUSIP
743187106
All holders as of
Q2 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q2 1 0 $0
2021 Q1 1 0 $0
2020 Q4 1 0 $0
2020 Q3 1 0 $0
2020 Q2 4 168 k $177 k
2020 Q1 137 58.4 M $222 M
2019 Q4 142 66.9 M $341 M
2019 Q3 149 67.8 M $343 M
2019 Q2 164 67.6 M $417 M
2019 Q1 162 68.4 M $318 M
2018 Q4 168 75.0 M $315 M
2018 Q3 172 78.9 M $495 M
2018 Q2 172 65.0 M $523 M
2018 Q1 166 66.5 M $481 M
2017 Q4 166 61.0 M $363 M
2017 Q3 157 59.4 M $428 M
2017 Q2 167 63.2 M $429 M
2017 Q1 175 65.1 M $614 M
2016 Q4 139 60.3 M $521 M
2016 Q3 128 60.3 M $382 M
2016 Q2 110 58.9 M $249 M
2016 Q1 126 60.5 M $264 M
2015 Q4 127 62.5 M $383 M
2015 Q3 139 67.5 M $392 M
2015 Q2 132 67.2 M $501 M
2015 Q1 116 65.1 M $389 M
2014 Q4 108 61.8 M $466 M
2014 Q3 87 56.5 M $293 M
2014 Q2 87 57.8 M $249 M
2014 Q1 97 52.2 M $214 M